Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Shenzhen Stock Exchange 002675.SZ
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT for the year ending December 31, 2023: USD 53.75 M
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT for the year ending December 31, 2022 was USD 72.29 M, a 5.57% change year over year.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT for the year ending December 31, 2021 was USD 68.48 M, a -32.43% change year over year.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT for the year ending December 31, 2020 was USD 101.35 M, a 55.17% change year over year.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT for the year ending December 31, 2019 was USD 65.31 M, a -13.33% change year over year.
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Don’t Miss A Beat
| CEO | Mr. Zhi Gang Luo |
| IPO Date | May 25, 2012 |
| Location | China |
| Headquarters | No.7 ChangBaiShan Road |
| Employees | 2,333 |
| Sector | Health Care |
| Industries | |
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Past 5 years
USD 1.40
USD 2.36
USD 0.95
USD 2.42
USD 4.11
StockViz Staff
February 1, 2025
Any question? Send us an email